Click here to submit Post PR News
Feedback Form
Per Page :

Granules Pharmaceuticals, Inc., the wholly owned subsidiary of Granules India Ltd., launched generic Methylergonovine tablets in partnership with Hikma

Hyderabad India – May 30th 2018 Granules Pharmaceuticals, Inc., the wholly owned subsidiary of Granules India Ltd., has launched the generic version of Methylergonovine Maleate Tablets, USP, 0.2mg, the generic equivalent to Methergine in partnership with WestWard Pharmaceuticals Corp. (West-Ward),  →
0 Views : 117

Cipla Receives Final Approval for Generic Depo-Testosterone® (Testosterone Cypionate for Injection 100mg/ml and 200mg/ml)

Mumbai, India, June 21, 2018 Cipla Limited (“Cipla”), today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Testosterone Cypionate Injection 100mg/ml and 200mg/ml from the United States Food and Drug Administration (US FDA).  →
0 Views : 106

Sun Pharma receives EIR for Halol facility

Mumbai, India, June 12, 2018 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced that it has received the Establishment Inspection Report (EIR) from the US FDA for the inspection conducted at its Halol  →
0 Views : 142

Pharmaceutical firms ramp up investment in security products to secure critical data

Pharmaceutical firms require efficient technologies such as Internet of Things (IoT), cloud computing, artificial intelligence and big data to manage info that is important to the development and production of successful drugs. As a result, pharmaceutical corporations are increasing their investment on varied security products to stop breaches, protect patient data and secure sensitive information. According to a survey, 79% of pharmaceutical firms are presently investments in identity  →
0 Views : 163

French pharmaceutical market to stagnate as government holds generics to cut healthcare spending

The pharmaceuticals drugs market in France is prepared to decline from $35.5 billion in 2017 to $34.16 billion in 2021, representing a negative compound annual rate of growth of 1%, according during the forecast period. Latest reports states that in spite of France’s strong public health insurance system and rising senior population, increasing pressure on  →
0 Views : 148

Glenmark’s consolidated revenue at Rs. 22,798.16 Mn. for Q4 FY 2017 – 18

Mumbai, India, May 29, 2018 Glenmark Pharmaceuticals Limited, a research-led global integrated pharmaceutical company, today announced its financial results for the fourth quarter and year ended March 31, 2018. For the fourth quarter ended March 31, 2018, Glenmark’s consolidated revenue  →
0 Views : 127

Age-related macular degeneration market will rise to $11.5 billion by 2026

Pharmaceutical sales for age-related macular degeneration (AMD) marketplaces were projected to be $4.9 billion in 2016, and it’s expected to reach a price of $11.5 billion in 2026, with a Compound Annual Growth Rate (CAGR) rise of 8.9%, stated by  →
0 Views : 138


11 November 2017 The ninth edition of BIOFACH INDIA together with INDIA ORGANIC 2017 concluded at India Expo Mart Limited (IEML), Greater Noida, Delhi-NCR on 11 November 2017 with a resounding success. The three-day exhibition witnessed an overwhelming response from  →
0 Views : 109

The German pharmaceuticals market expected to grow to $86.3 billion in 2021

June 19, 2017 GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Germany”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Germany.  →
0 Views : 370

Abengoa Bioenergia, S.A. – Biotechnology Company

Abengoa Bioenergia, S.A. (Abengoa Bioenergy), a subsidiary of Abengoa, S.A., is a biotechnology company that develops new technologies for the production of biofuels and chemical bioproducts. Abengoa Bioenergy specializes in the development of innovative technology solutions contributing to the sustainability  →
0 Views : 544

Create Free Account

You can create a free account with us to gain access to just released news and press releases about leading companies from across the world. Your free account can provide you with the latest industry and corporate information to help you take quick business decisions. With your free account, you can be amongst the first ones to know of the latest happenings. So Signup now !!.